AdvanSix (NYSE: ASIX), a vertically integrated chemistry company serving diverse end markets, today announced its financial results for the second quarter ending June 30, 2026.

Second Quarter 2026 Summary

“Our resilient second quarter results reflected a significant sequential improvement in earnings and cash flow amid what remains a highly dynamic macro environment, particularly in Plant Nutrients,” said Erin Kane, president and CEO of AdvanSix. “We generated 3% sales growth year-over-year as our commercial teams continued to leverage both formula and market-based pricing mechanisms to offset inflationary raw material costs. Sales volume in the quarter fell short of expectations due to a decline in ammonium sulfate as the spring planting season was challenged by farmer profitability and resulting fertilizer consumption overall. Nylon Solutions and Chemical Intermediates both performed at or better than expectations as we continue to navigate a subdued industrial end market demand environment. We have a demonstrated track record of successfully performing through a multitude of environments and remain confident in our ability to deliver long-term value.”

Summary second quarter 2026 financial results for the Company are included below:

($ in Thousands, Except Earnings Per Share)

 

2Q 2026

 

2Q 2025

 

Variance $

 

Variance %

Sales

 

$421,284

 

$410,022

 

$11,262

 

3%

Net Income

 

3,248

 

31,371

 

(28,123)

 

(90%)

Diluted Earnings Per Share

 

0.12

 

1.15

 

(1.03)

 

(90%)

Adjusted Diluted Earnings Per Share (1)

 

0.19

 

1.24

 

(1.05)

 

(85%)

Adjusted EBITDA (1)

 

31,888

 

55,675

 

(23,787)

 

(43%)

Adjusted EBITDA Margin % (1)

 

7.6%

 

13.6%

 

(600) bps

 

n/a

Cash Flow from Operations

 

10,038

 

21,110

 

(11,072)

 

(52%)

Capital Expenditures

 

20,714

 

28,265

 

(7,551)

 

(27%)

Free Cash Flow (1)(2)

 

(10,676)

 

(7,155)

 

(3,521)

 

(49%)

(1) See “Non-GAAP Measures” included in this press release for non-GAAP reconciliations

(2) Net cash provided by operating activities less capital expenditures

Sales of $421 million in the quarter increased approximately 3% versus the prior year driven by 18% favorable pricing, partially offset by a 15% decline in volume. Raw material pass-through pricing was up 13% following a net cost increase in benzene and propylene (inputs to cumene which is a key feedstock to our products). Market-based pricing improved by 5% primarily driven by an increase in Plant Nutrients reflecting higher nitrogen pricing amid increased sulfur input costs. Lower sales volume was primarily driven by more challenging agricultural fundamentals including farmer economics, which resulted in a reduction of in-season fertilizer purchases.

Sales by product line and approximate percentage of total sales are included below:

($ in Thousands)

 

2Q 2026

 

2Q 2025

 

 

 

 

Sales

 

% of Total

 

Sales

 

% of Total

 

Variance %

Nylon

 

$

100,218

 

24

%

 

$

79,503

 

20

%

 

26

%

Caprolactam

 

 

62,644

 

15

%

 

 

66,424

 

16

%

 

(6

%)

Plant Nutrients

 

 

131,439

 

31

%

 

 

156,770

 

38

%

 

(16

%)

Chemical Intermediates

 

 

126,983

 

30

%

 

 

107,325

 

26

%

 

18

%

Total

 

$

421,284

 

100

%

 

$

410,022

 

100

%

 

3

%

Adjusted EBITDA of $31.9 million in the quarter decreased $23.8 million versus the prior year primarily driven by the unfavorable impact of lower sales volume in Plant Nutrients and reduced production output, partially offset by a planned reduction in SG&A expense.

Adjusted earnings per share of $0.19 decreased $1.05 versus the prior year driven primarily by the factors discussed above and a higher effective tax rate driven primarily by 45Q carbon capture tax credits claimed in the prior year period.

Cash flow from operations of $10.0 million in the quarter decreased $11.1 million versus the prior year primarily due to lower net income. Capital expenditures of $20.7 million in the quarter decreased $7.6 million versus the prior year, as expected.

Outlook

  • North American ammonium sulfate fill program expected to drive 3Q26 sequential domestic pricing decline amid competitive dynamics and continued higher sulfur input cost environment

  • Acetone spread over propylene costs expected to hold near cycle averages for the full year 2026

  • Continue to optimize Nylon Solutions production output, inventories and sales volume mix in extended soft industrial end market environment

  • Continue to expect Capital Expenditures of $75 to $95 million in 2026 versus $116 million in 2025, reflecting risk-based prioritization of base investments and enterprise programs with continued progression of growth programs including SUSTAIN

  • Now expect pre-tax income impact of plant turnarounds to be approximately $17 million in 2026 versus approximately $25 million in 2025

  • Expect 2H 2026 sequential cash flow improvement primarily due to a reduced Capital Expenditures run-rate, working capital tailwinds including our 4Q 2026 pre-buy program in Plant Nutrients, timing of annual payments paid in 1H 2026, and cash tax optimization

“Key to our strategy is a keen focus on controllable levers to support through-cycle profitability and cash conversion, while progressing targeted growth strategies and initiatives. We remain focused on delivering on our non-manpower fixed cost savings program, risk-based prioritization of our capital investments, continued working capital discipline and 45Q carbon capture tax credits to support improved cash flow generation. As we move through the remainder of 2026 and navigate the current industry environment, we are well positioned to support our strategic priorities as a U.S.-based integrated manufacturer aligned to domestic supply chains and energy markets as well as a diverse set of end market applications,” concluded Kane.

Dividend

The Company’s Board of Directors declared a quarterly cash dividend of $0.16 per share on the Company’s common stock. The dividend is payable on September 1, 2026 to stockholders of record as of the close of business on August 18, 2026.

Conference Call Information

AdvanSix will discuss its results during its investor conference call today starting at 9:30 a.m. ET. To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start, and tell the operator that you are dialing in for AdvanSix’s second quarter 2026 earnings call. The live webcast of the investor call as well as related presentation materials can be accessed at http://investors.advansix.com. Investors can hear a replay of the conference call from 12 noon ET on August 7 until 12 noon ET on August 14 by dialing (855) 669-9658 (domestic) or (412) 317-0088 (international). The access code is 2279374.

About AdvanSix

AdvanSix is a vertically integrated chemistry company that produces essential materials for our customers across diverse end markets. Our value chain of our five U.S.-based manufacturing facilities plays a critical role in global supply chains and enables us to innovate and deliver essential products for our customers across building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, electronics and other end markets. Guided by our core values of Safety, Integrity, Accountability and Respect, AdvanSix strives to deliver best-in-class customer experiences and differentiated products in the industries of nylon solutions, plant nutrients, and chemical intermediates. More information on AdvanSix can be found at http://www.advansix.com.

Forward Looking Statements

This release contains certain statements that may be deemed “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, that address activities, events or developments that our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements may be identified by words such as “expect,” “anticipate,” “estimate,” “outlook,” “project,” “strategy,” “intend,” “plan,” “target,” “goal,” “may,” “will,” “should” and “believe” and other variations or similar terminology and expressions. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks, uncertainties and other factors, many of which are beyond our control and difficult to predict, which may cause the actual results or performance of the Company to be materially different from any future results or performance expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: general economic and financial conditions in the U.S. and globally; the potential effects of inflationary pressures, tariffs or the imposition of new tariffs, trade wars, barriers or restrictions, or threats of such actions, changes in interest rates, labor market shortages and supply chain issues; instability or volatility in financial markets or other unfavorable economic or business conditions caused by geopolitical concerns, including as a result of new or proposed legislation or regulatory, trade or other policies in or impacting the U.S., the conflict between Russia and Ukraine, the conflicts in the Middle East, as well as any related uncertainty in the surrounding region, and the possible expansion of such conflicts; the effect of any of the foregoing on our customers’ demand for our products and our suppliers’ ability to manufacture and deliver our raw materials, including implications of reduced refinery utilization in the U.S.; our ability to sell and provide our goods and services; the ability of our customers to pay for our products; any closures of our and our customers’ offices and facilities; risks associated with increased phishing, compromised business emails and other cybersecurity attacks, data privacy incidents and disruptions to our technology infrastructure; risks associated with potential use of artificial intelligence in our operations or those of third party service providers; risks associated with operating with a reduced workforce; risks associated with our indebtedness including compliance with financial and restrictive covenants, and our ability to access capital on reasonable terms, at a reasonable cost, or at all, due to economic conditions or otherwise; the impact of scheduled turnarounds and significant unplanned downtime and interruptions of production or logistics operations as a result of mechanical issues or other unanticipated events such as fires, severe weather conditions, natural disasters, pandemics, geopolitical conflicts and related events; price fluctuations, cost increases and supply of raw materials; our operations and growth projects requiring substantial capital; growth rates and cyclicality of the industries we serve including global changes in supply and demand; failure to develop and commercialize new products or technologies; loss of significant customer relationships; adverse trade and tax policies; extensive environmental, health and safety laws that apply to our operations; hazards associated with chemical manufacturing, storage and transportation; litigation associated with chemical manufacturing and our business operations generally; inability to acquire and integrate businesses, assets, products or technologies; protection of our intellectual property and proprietary information; prolonged work stoppages as a result of labor difficulties or otherwise; failure to maintain effective internal controls; our ability to declare and pay quarterly cash dividends and the amounts and timing of any future dividends; our ability to repurchase our common stock and the amount and timing of any future repurchases; disruptions in supply chain, transportation and logistics; potential for uncertainty regarding qualification for tax treatment of our spin-off; fluctuations in our stock price; and changes in laws or regulations applicable to our business. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ materially from those contemplated by such forward-looking statements as a result of a number of risks, uncertainties and other factors including those noted above and those identified in our filings with the Securities and Exchange Commission (SEC), including the risk factors in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025, as updated in subsequent reports filed with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. We do not undertake to update or revise any of our forward-looking statements.

Non-GAAP Financial Measures

This press release includes certain non-GAAP financial measures intended to supplement, not to act as substitutes for, comparable GAAP measures. Reconciliations of non-GAAP financial measures to GAAP financial measures are provided in this press release. Investors are urged to consider carefully the comparable GAAP measures and the reconciliations to those measures provided. Non-GAAP measures in this press release may be calculated in a way that is not comparable to similarly-titled measures reported by other companies.

AdvanSix Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

(Dollars in thousands, except share and per share amounts)

 

 

 

June 30, 2026

 

December 31, 2025

ASSETS

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

 

$

7,217

 

 

$

19,766

 

Accounts and other receivables – net

 

 

187,429

 

 

 

154,102

 

Inventories – net

 

 

194,145

 

 

 

236,495

 

Taxes receivable

 

 

20,510

 

 

 

21,605

 

Other current assets

 

 

15,560

 

 

 

8,639

 

Total current assets

 

 

424,861

 

 

 

440,607

 

Property, plant and equipment – net

 

 

964,867

 

 

 

963,718

 

Operating lease right-of-use assets

 

 

147,454

 

 

 

164,494

 

Goodwill

 

 

56,192

 

 

 

56,192

 

Intangible assets

 

 

38,570

 

 

 

40,095

 

Other assets

 

 

41,072

 

 

 

41,042

 

Total assets

 

$

1,673,016

 

 

$

1,706,148

 

 

 

 

 

 

LIABILITIES

 

 

 

 

Current liabilities:

 

 

 

 

Accounts payable

 

$

243,287

 

 

$

284,016

 

Accrued liabilities

 

 

43,558

 

 

 

45,945

 

Income taxes payable

 

 

73

 

 

 

1,100

 

Operating lease liabilities – short-term

 

 

42,841

 

 

 

44,354

 

Deferred income and customer advances

 

 

1,980

 

 

 

14,536

 

Total current liabilities

 

 

331,739

 

 

 

389,951

 

Deferred income taxes

 

 

152,172

 

 

 

154,061

 

Operating lease liabilities – long-term

 

 

106,100

 

 

 

121,201

 

Line of credit – long-term

 

 

275,000

 

 

 

215,000

 

Other liabilities

 

 

11,093

 

 

 

10,719

 

Total liabilities

 

 

876,104

 

 

 

890,932

 

 

 

 

 

 

STOCKHOLDERS’ EQUITY

 

 

 

 

Common stock, par value $0.01; 200,000,000 shares authorized; 33,393,066 shares issued and 27,001,186 outstanding at June 30, 2026; 33,177,824 shares issued and 26,864,035 outstanding at December 31, 2025

 

 

334

 

 

 

332

 

Preferred stock, par value $0.01; 50,000,000 shares authorized; 0 shares issued and outstanding at June 30, 2026 and December 31, 2025

 

 

 

 

 

 

Treasury stock at par (6,391,880 shares at June 30, 2026; 6,313,789 shares at December 31, 2025)

 

 

(64

)

 

 

(63

)

Additional paid-in capital

 

 

145,991

 

 

 

142,932

 

Retained earnings

 

 

641,669

 

 

 

663,019

 

Accumulated other comprehensive income

 

 

8,982

 

 

 

8,996

 

Total stockholders’ equity

 

 

796,912

 

 

 

815,216

 

Total liabilities and stockholders’ equity

 

$

1,673,016

 

 

$

1,706,148

 

AdvanSix Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

(Dollars in thousands, except share and per share amounts)

 

 

 

Three Months Ended

June 30,

 

Six Months Ended

June 30,

 

 

2026

 

2025

 

2026

 

2025

Sales

 

$

421,284

 

 

$

410,022

 

 

$

825,468

 

 

$

787,813

 

 

 

 

 

 

 

 

 

 

Costs, expenses and other:

 

 

 

 

 

 

 

 

Cost of goods sold

 

 

390,183

 

 

 

351,308

 

 

 

790,565

 

 

 

675,628

 

Selling, general and administrative expenses

 

 

22,054

 

 

 

25,416

 

 

 

44,572

 

 

 

48,825

 

Interest expense, net

 

 

2,608

 

 

 

2,255

 

 

 

5,038

 

 

 

3,796

 

Other non-operating income, net

 

 

(215

)

 

 

(607

)

 

 

(684

)

 

 

(1,015

)

Total costs, expenses and other

 

 

414,630

 

 

 

378,372

 

 

 

839,491

 

 

 

727,234

 

 

 

 

 

 

 

 

 

 

Income (loss) before taxes

 

 

6,654

 

 

 

31,650

 

 

 

(14,023

)

 

 

60,579

 

Income tax expense (benefit)

 

 

3,406

 

 

 

279

 

 

 

(1,725

)

 

 

5,864

 

Net income (loss)

 

$

3,248

 

 

$

31,371

 

 

$

(12,298

)

 

$

54,715

 

 

 

 

 

 

 

 

 

 

Earnings per common share

 

 

 

 

 

 

 

 

Basic

 

$

0.12

 

 

$

1.17

 

 

$

(0.46

)

 

$

2.04

 

Diluted

 

$

0.12

 

 

$

1.15

 

 

$

(0.46

)

 

$

2.01

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

 

 

 

 

 

 

Basic

 

 

27,046,372

 

 

 

26,896,037

 

 

 

27,013,738

 

 

 

26,867,252

 

Diluted

 

 

27,602,088

 

 

 

27,223,309

 

 

 

27,013,738

 

 

 

27,248,976

 

AdvanSix Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(Dollars in thousands)

   

 

 

Three Months Ended

June 30,

 

Six Months Ended

June 30,

 

 

2026

 

2025

 

2026

 

2025

Cash flows from operating activities:

 

 

 

 

 

 

 

 

Net income (loss)

 

$

3,248

 

 

$

31,371

 

 

$

(12,298

)

 

$

54,715

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

20,793

 

 

 

19,461

 

 

 

41,751

 

 

 

38,639

 

(Gain) loss on disposal of assets

 

 

130

 

 

 

33

 

 

 

134

 

 

 

(177

)

Deferred income taxes

 

 

1,531

 

 

 

2,592

 

 

 

(1,889

)

 

 

6,646

 

Stock-based compensation

 

 

1,833

 

 

 

2,309

 

 

 

3,878

 

 

 

4,287

 

Amortization of deferred financing fees

 

 

181

 

 

 

154

 

 

 

304

 

 

 

309

 

Changes in assets and liabilities, net of business acquisitions:

 

 

 

 

 

 

 

 

Accounts and other receivables

 

 

20,156

 

 

 

19,658

 

 

 

(33,341

)

 

 

(13,994

)

Inventories

 

 

7,213

 

 

 

1,093

 

 

 

42,350

 

 

 

(9,378

)

Taxes receivable

 

 

1,582

 

 

 

(15,188

)

 

 

1,095

 

 

 

(14,740

)

Accounts payable

 

 

(39,096

)

 

 

(6,939

)

 

 

(22,934

)

 

 

12,423

 

Income taxes payable

 

 

(506

)

 

 

(2,206

)

 

 

(1,027

)

 

 

(663

)

Accrued liabilities

 

 

13,162

 

 

 

5,510

 

 

 

(2,001

)

 

 

561

 

Deferred income and customer advances

 

 

(9,323

)

 

 

(24,724

)

 

 

(12,556

)

 

 

(35,680

)

Other assets and liabilities

 

 

(10,866

)

 

 

(12,014

)

 

 

(8,760

)

 

 

(10,395

)

Net cash provided by (used for) operating activities

 

 

10,038

 

 

 

21,110

 

 

 

(5,294

)

 

 

32,553

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Expenditures for property, plant and equipment

 

 

(20,714

)

 

 

(28,265

)

 

 

(56,650

)

 

 

(62,327

)

Other investing activities

 

 

5

 

 

 

(3,159

)

 

 

(222

)

 

 

(5,891

)

Net cash used for investing activities

 

 

(20,709

)

 

 

(31,424

)

 

 

(56,872

)

 

 

(68,218

)

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Borrowings from line of credit

 

 

122,000

 

 

 

113,000

 

 

 

261,500

 

 

 

231,500

 

Repayments of line of credit

 

 

(117,000

)

 

 

(88,000

)

 

 

(201,500

)

 

 

(186,500

)

Principal payments of finance leases

 

 

(250

)

 

 

(244

)

 

 

(513

)

 

 

(491

)

Dividend payments

 

 

(4,314

)

 

 

(4,290

)

 

 

(8,627

)

 

 

(8,580

)

Purchase of treasury stock

 

 

(122

)

 

 

(51

)

 

 

(1,397

)

 

 

(1,537

)

Issuance of common stock

 

 

 

 

 

1

 

 

 

154

 

 

 

155

 

Net cash provided by financing activities

 

 

314

 

 

 

20,416

 

 

 

49,617

 

 

 

34,547

 

 

 

 

 

 

 

 

 

 

Net change in cash and cash equivalents

 

 

(10,357

)

 

 

10,102

 

 

 

(12,549

)

 

 

(1,118

)

Cash and cash equivalents at beginning of period

 

 

17,574

 

 

 

8,344

 

 

 

19,766

 

 

 

19,564

 

Cash and cash equivalents at the end of period

 

$

7,217

 

 

$

18,446

 

 

$

7,217

 

 

$

18,446

 

 

 

 

 

 

 

 

 

 

Supplemental non-cash investing activities:

 

 

 

 

 

 

 

 

Capital expenditures included in accounts payable

 

 

 

 

 

$

9,301

 

 

$

14,762

 

AdvanSix Inc.

Non-GAAP Measures

(Dollars in thousands, except share and per share amounts)

 

Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow

   

 

 

Three Months Ended

June 30,

 

Six Months Ended

June 30,

 

 

2026

 

2025

 

2026

 

2025

Net cash provided by (used for) operating activities

 

$

10,038

 

 

$

21,110

 

 

$

(5,294

)

 

$

32,553

 

Expenditures for property, plant and equipment

 

 

(20,714

)

 

 

(28,265

)

 

 

(56,650

)

 

 

(62,327

)

Free cash flow (1)

 

$

(10,676

)

 

$

(7,155

)

 

$

(61,944

)

 

$

(29,774

)

 

 

 

 

 

 

 

 

 

(1) Free cash flow is a non-GAAP measure defined as Net cash provided by operating activities less Expenditures for property, plant and equipment.

The Company believes that this metric is useful to investors and management as a measure to evaluate our ability to generate cash flow from business operations and the impact that this cash flow has on our liquidity.

Reconciliation of Net Income to Adjusted EBITDA and Earnings Per Share to Adjusted Earnings Per Share

 

 

 

Three Months Ended

June 30,

 

Six Months Ended

June 30,

 

 

2026

 

2025

 

2026

 

2025

Net income (loss)

 

$

3,248

 

 

$

31,371

 

 

$

(12,298

)

 

$

54,715

 

Non-cash stock-based compensation

 

 

1,833

 

 

 

2,309

 

 

 

3,878

 

 

 

4,287

 

Non-cash amortization from acquisitions

 

 

531

 

 

 

531

 

 

 

1,063

 

 

 

1,063

 

Strategic advisory and professional fees

 

 

 

 

 

 

 

 

 

 

 

 

Income tax benefit relating to reconciling items

 

 

(408

)

 

 

(479

)

 

 

(848

)

 

 

(909

)

Adjusted Net income (loss) (non-GAAP)

 

 

5,204

 

 

 

33,732

 

 

 

(8,205

)

 

 

59,156

 

Interest expense, net

 

 

2,608

 

 

 

2,255

 

 

 

5,038

 

 

 

3,796

 

Income tax expense (benefit) – Adjusted

 

 

3,814

 

 

 

758

 

 

 

(877

)

 

 

6,773

 

Depreciation and amortization – Adjusted

 

 

20,262

 

 

 

18,930

 

 

 

40,688

 

 

 

37,576

 

Adjusted EBITDA (non-GAAP)

 

$

31,888

 

 

$

55,675

 

 

$

36,644

 

 

$

107,301

 

 

 

 

 

 

 

 

 

 

Sales

 

$

421,284

 

 

$

410,022

 

 

$

825,468

 

 

$

787,813

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA Margin (non-GAAP) (2)

 

7.6%

 

13.6%

 

4.4%

 

13.6%

 

 

 

 

 

 

 

 

 

(2) Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by Sales

 

 

Three Months Ended

June 30,

 

Six Months Ended

June 30,

 

 

2026

 

2025

 

2026

 

2025

Net income (loss)

 

$

3,248

 

$

31,371

 

$

(12,298

)

 

$

54,715

Adjusted Net income (loss) (non-GAAP)

 

 

5,204

 

 

33,732

 

 

(8,205

)

 

 

59,156

 

 

 

 

 

 

 

 

 

Weighted-average number of common shares outstanding – basic

 

 

27,046,372

 

 

26,896,037

 

 

27,013,738

 

 

 

26,867,252

Dilutive effect of equity awards and other stock-based holdings

 

 

555,716

 

 

327,272

 

 

 

 

 

381,724

Weighted-average number of common shares outstanding – diluted

 

 

27,602,088

 

 

27,223,309

 

 

27,013,738

 

 

 

27,248,976

 

 

 

 

 

 

 

 

 

EPS – Basic

 

$

0.12

 

$

1.17

 

$

(0.46

)

 

$

2.04

EPS – Diluted

 

$

0.12

 

$

1.15

 

$

(0.46

)

 

$

2.01

Adjusted EPS – Basic (non-GAAP)

 

$

0.19

 

$

1.25

 

$

(0.30

)

 

$

2.20

Adjusted EPS – Diluted (non-GAAP)

 

$

0.19

 

$

1.24

 

$

(0.30

)

 

$

2.17

 

The Company believes the non-GAAP financial measures presented in this release provide meaningful supplemental information as they are used by the Company’s management to evaluate the Company’s operating performance, enhance a reader’s understanding of the financial performance of the Company, and facilitate a better comparison among fiscal periods and performance relative to its competitors, as these non-GAAP measures exclude items that are not considered core to the Company’s operations.

AdvanSix Inc.

Appendix

(Pre-tax income impact, Dollars in millions)

 

Planned Plant Turnaround Schedule (3)

 

 

 

1Q

 

2Q

 

3Q

 

4Q

 

FY

 

Primary Unit Operation

2017

 

 

~$10

 

~$4

 

~$20

 

~$34

 

Sulfuric Acid

2018

 

~$2

 

~$10

 

~$30

 

 

~$42

 

Ammonia

2019

 

 

~$5

 

~$5

 

~$25

 

~$35

 

Sulfuric Acid

2020

 

~$2

 

~$7

 

~$20

 

~$2

 

~$31

 

Ammonia

2021

 

~$3

 

~$8

 

 

~$18

 

~$29

 

Sulfuric Acid

2022

 

~$1

 

~$5

 

~$44(4)

 

 

~$50

 

Ammonia

2023

 

~$2

 

~$1

 

~$27

 

 

~$30

 

Sulfuric Acid

2024

 

~$5

 

~$3

 

~$3

 

~$47(5)

 

~$58

 

Ammonia

2025

 

~$5

 

~$6

 

 

~$14

 

~$25

 

Sulfuric Acid

2026E

 

 

~$10

 

 

~$7

 

~$17

 

Ammonia

 

(3) Primarily reflects the impact of fixed cost absorption, maintenance expense, and the purchase of feedstocks which are normally manufactured by the Company.

(4) During the multi-site planned plant turnaround, additional required maintenance at our Frankford phenol plant contributed to reduced production across our integrated value chain and a delayed ramp to full operating rates at our Hopewell and Chesterfield sites, resulting in an incremental $15 million unfavorable impact to pre-tax income, which is reflected in this amount and is inclusive of fixed cost absorption, higher maintenance expense and lost sales.

(5) During the multi-site planned plant turnaround, additional required maintenance at our Hopewell plant contributed to reduced production across our integrated value chain and a delayed ramp to full operating rates, resulting in an incremental approximately $17 million unfavorable impact to pre-tax income, which is reflected in this amount and is inclusive of fixed cost absorption, higher maintenance expense, and lost sales.

 

Media gallery

About The Author